Presumed pseudokinase VRK3 functions as a BAF kinase

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1853, Issue 7, 2015, Pages 1738-1748

  Park, Choon Ho ^a   Ryu, Hye Guk ^a   Kim, Seong Hoon ^a   Lee, Dohyun ^a   Song, Haengjin ^a   Kim, Kyong Tai ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

Barrier to autointegration factor; Pseudokinase; Vaccinia related kinase 3

Indexed keywords

BARRIER TO AUTOINTEGRATION FACTOR; CYCLIN B; CYCLIN E; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG; VACCINIA RELATED KINASE 3; BANF1 PROTEIN, HUMAN; DNA BINDING PROTEIN; NUCLEAR PROTEIN; PHOSPHOSERINE; PROTEIN BINDING; PROTEIN SERINE THREONINE KINASE; VRK3 PROTEIN, HUMAN; VRK3 PROTEIN, MOUSE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL NUCLEUS; CELL NUCLEUS MEMBRANE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CRYSTAL STRUCTURE; CYTOPLASM; DNA REPLICATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HEK293 CELL LINE; HELA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERPHASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; ANIMAL; BIOLOGICAL MODEL; CELL CYCLE; CHEMISTRY; METABOLISM; PHOSPHORYLATION; PROTEIN TRANSPORT; STRUCTURE ACTIVITY RELATION;

ANIMALS; CELL CYCLE; DNA-BINDING PROTEINS; HEK293 CELLS; HELA CELLS; HUMANS; MICE; MODELS, BIOLOGICAL; NUCLEAR ENVELOPE; NUCLEAR PROTEINS; PHOSPHORYLATION; PHOSPHOSERINE; PROTEIN BINDING; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84928711673     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2015.04.007     Document Type: Article

References (44)

1. Asencio C., Davidson I.F., Santarella-Mellwig R., Ly-Hartig T.B., Mall M., Wallenfang M.R., Mattaj I.W., Gorjanacz M. Coordination of kinase and phosphatase activities by Lem4 enables nuclear envelope reassembly during mitosis. Cell 2012, 150:122-135.
2. Bengtsson L., Wilson K.L. Barrier-to-autointegration factor phosphorylation on Ser-4 regulates emerin binding to lamin A in vitro and emerin localization in vivo. Mol. Biol. Cell 2006, 17:1154-1163.
3. Boudeau J., Miranda-Saavedra D., Barton G.J., Alessi D.R. Emerging roles of pseudokinases. Trends Cell Biol. 2006, 16:443-452.
4. Brennan D.F., Dar A.C., Hertz N.T., Chao W.C., Burlingame A.L., Shokat K.M., Barford D. A Raf-induced allosteric transition of KSR stimulates phosphorylation of MEK. Nature 2011, 472:366-369.
5. Brill L.M., Xiong W., Lee K.B., Ficarro S.B., Crain A., Xu Y., Terskikh A., Snyder E.Y., Ding S. Phosphoproteomic analysis of human embryonic stem cells. Cell Stem Cell 2009, 5:204-213.
6. Conner S.D., Schmid S.L. CVAK104 is a novel poly-L-lysine-stimulated kinase that targets the beta2-subunit of AP2. J. Biol. Chem. 2005, 280:21539-21544.
7. Dar A.C. A pickup in pseudokinase activity. Biochem. Soc. Trans. 2013, 41:987-994.
8. Dhavan R., Tsai L.H. A decade of CDK5. Nat. Rev. Mol. Cell Biol. 2001, 2:749-759.
9. Gorjanacz M. LEM-4 promotes rapid dephosphorylation of BAF during mitotic exit. Nucleus 2013, 4:14-17.
10. Gorjanacz M., Klerkx E.P., Galy V., Santarella R., Lopez-Iglesias C., Askjaer P., Mattaj I.W. Caenorhabditis elegans BAF-1 and its kinase VRK-1 participate directly in post-mitotic nuclear envelope assembly. EMBO J. 2007, 26:132-143.
11. Haraguchi T., Koujin T., Osakada H., Kojidani T., Mori C., Masuda H., Hiraoka Y. Nuclear localization of barrier-to-autointegration factor is correlated with progression of S phase in human cells. J. Cell Sci. 2007, 120:1967-1977.
12. Hsu P.P., Kang S.A., Rameseder J., Zhang Y., Ottina K.A., Lim D., Peterson T.R., Choi Y., Gray N.S., Yaffe M.B., Marto J.A., Sabatini D.M. The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 2011, 332:1317-1322.
13. Hu Q., Noll R.J., Li H., Makarov A., Hardman M., Graham Cooks R. The Orbitrap: a new mass spectrometer. J. Mass Spectrom. 2005, 40:430-443.
14. Hunter T. Signaling-2000 and beyond. Cell 2000, 100:113-127.
15. Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P. A tissue-specific atlas of mouse protein phosphorylation and expression. Cell 2010, 143:1174-1189.
16. Kang T.H., Kim K.T. Negative regulation of ERK activity by VRK3-mediated activation of VHR phosphatase. Nat. Cell Biol. 2006, 8:863-869.
17. Kang T.H., Kim K.T. VRK3-mediated inactivation of ERK signaling in adult and embryonic rodent tissues. Biochim. Biophys. Acta 2008, 1783:49-58.
18. Kang T.H., Park D.Y., Choi Y.H., Kim K.J., Yoon H.S., Kim K.T. Mitotic histone H3 phosphorylation by vaccinia-related kinase 1 in mammalian cells. Mol. Cell. Biol. 2007, 27:8533-8546.
19. Kannan N., Taylor S.S. Rethinking pseudokinases. Cell 2008, 133:204-205.
20. Kim W., Chakraborty G., Kim S., Shin J., Park C.H., Jeong M.W., Bharatham N., Yoon H.S., Kim K.T. Macro histone H2A1.2 (macroH2A1) protein suppresses mitotic kinase VRK1 during interphase. J. Biol. Chem. 2012, 287:5278-5289.
21. Klerkx E.P., Lazo P.A., Askjaer P. Emerging biological functions of the vaccinia-related kinase (VRK) family. Histol. Histopathol. 2009, 24:749-759.
22. Kornev A.P., Taylor S.S. Pseudokinases: functional insights gleaned from structure. Structure 2009, 17:5-7.
23. Manning G., Whyte D.B., Martinez R., Hunter T., Sudarsanam S. The protein kinase complement of the human genome. Science 2002, 298:1912-1934.
24. Margalit A., Brachner A., Gotzmann J., Foisner R., Gruenbaum Y. Barrier-to-autointegration factor-a BAFfling little protein. Trends Cell Biol. 2007, 17:202-208.
25. Margalit A., Neufeld E., Feinstein N., Wilson K.L., Podbilewicz B., Gruenbaum Y. Barrier to autointegration factor blocks premature cell fusion and maintains adult muscle integrity in C. elegans. J. Cell Biol. 2007, 178:661-673.
26. Margalit A., Segura-Totten M., Gruenbaum Y., Wilson K.L. Barrier-to-autointegration factor is required to segregate and enclose chromosomes within the nuclear envelope and assemble the nuclear lamina. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:3290-3295.
27. Mukherjee K., Sharma M., Urlaub H., Bourenkov G.P., Jahn R., Sudhof T.C., Wahl M.C. CASK functions as a Mg2+-independent neurexin kinase. Cell 2008, 133:328-339.
28. Nichols R.J., Traktman P. Characterization of three paralogous members of the Mammalian vaccinia related kinase family. J. Biol. Chem. 2004, 279:7934-7946.
29. Nichols R.J., Wiebe M.S., Traktman P. The vaccinia-related kinases phosphorylate the N' terminus of BAF, regulating its interaction with DNA and its retention in the nucleus. Mol. Biol. Cell 2006, 17:2451-2464.
30. Park C.H., Choi B.H., Jeong M.W., Kim S., Kim W., Song Y.S., Kim K.T. Protein kinase Cdelta regulates vaccinia-related kinase 1 in DNA damage-induced apoptosis. Mol. Biol. Cell 2011, 22:1398-1408.
31. Park C.H., Kim K.T. Apoptotic phosphorylation of histone H3 on Ser-10 by protein kinase Cdelta. PLoS ONE 2012, 7:e44307.
32. Sanz-Garcia M., Monsalve D.M., Sevilla A., Lazo P.A. Vaccinia-related kinase 1 (VRK1) is an upstream nucleosomal kinase required for the assembly of 53BP1 foci in response to ionizing radiation-induced DNA damage. J. Biol. Chem. 2012, 287:23757-23768.
33. Schagger H. Tricine-SDS-PAGE. Nat. Protoc. 2006, 1:16-22.
34. Scheeff E.D., Eswaran J., Bunkoczi G., Knapp S., Manning G. Structure of the pseudokinase VRK3 reveals a degraded catalytic site, a highly conserved kinase fold, and a putative regulatory binding site. Structure 2009, 17:128-138.
35. Segura-Totten M., Wilson K.L. BAF: roles in chromatin, nuclear structure and retrovirus integration. Trends Cell Biol. 2004, 14:261-266.
36. Shi F., Telesco S.E., Liu Y., Radhakrishnan R., Lemmon M.A. ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:7692-7697.
37. Suzuki Y., Ogawa K., Koyanagi Y., Suzuki Y. Functional disruption of the moloney murine leukemia virus preintegration complex by vaccinia-related kinases. J. Biol. Chem. 2010, 285:24032-24043.
38. Taylor S.S., Kornev A.P. Yet another "active" pseudokinase, Erb3. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:8047-8048.
39. Taylor S.S., Shaw A., Hu J., Meharena H.S., Kornev A. Pseudokinases from a structural perspective. Biochem. Soc. Trans. 2013, 41:981-986.
40. Ungureanu D., Wu J., Pekkala T., Niranjan Y., Young C., Jensen O.N., Xu C.F., Neubert T.A., Skoda R.C., Hubbard S.R., Silvennoinen O. The pseudokinase domain of JAK2 is a dual-specificity protein kinase that negatively regulates cytokine signaling. Nat. Struct. Mol. Biol. 2011, 18:971-976.
41. Wu X., Tian L., Li J., Zhang Y., Han V., Li Y., Xu X., Li H., Chen X., Chen J., Jin W., Xie Y., Han J., Zhong C.Q. Investigation of receptor interacting protein (RIP3)-dependent protein phosphorylation by quantitative phosphoproteomics. Mol. Cell. Proteomics 2012, 11:1640-1651.
42. Zeqiraj E., van Aalten D.M. Pseudokinases-remnants of evolution or key allosteric regulators?. Curr. Opin. Struct. Biol. 2010, 20:772-781.
43. Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J., Mohammed S. Toward a comprehensive characterization of a human cancer cell phosphoproteome. J. Proteome Res. 2013, 12:260-271.
44. Zhuang X., Semenova E., Maric D., Craigie R. Dephosphorylation of barrier-to-autointegration factor by protein phosphatase 4 and its role in cell mitosis. J. Biol. Chem. 2014, 289:1119-1127.